Literature DB >> 17429207

Evaluating appropriateness of treatment for Crohn's disease: feasibility of an explicit approach.

Idris Guessous1, Pascal Juillerat, Valerie Pittet, Florian Froehlich, Bernard Burnand, Christian Mottet, Christian Felley, Pierre Michetti, John-Paul Vader.   

Abstract

BACKGROUND: Situations where practical therapeutic decisions differ from guidelines in the management of patients with Crohn's disease (CD) have been described through opinion surveys. The feasibility of actually documenting these situations using an explicit approach has not been examined.
OBJECTIVE: The aim of this study was to evaluate the feasibility of a retrospective application of appropriateness criteria to a population of CD patients.
METHODS: Medical records of a cohort of patients diagnosed with CD were systematically reviewed. We used appropriateness criteria for treatment of CD that had been developed by the European Panel on the Appropriateness of Crohn's Disease Therapy (EPACT). First we evaluated the level of precision of the elements abstracted from medical records needed in order to be able to apply these criteria. We then assessed the appropriateness of treatment for different CD categories. Only participants with at least one physician encounter during the preceding 6 months were included.
RESULTS: 260 patient medical records were reviewed on site at 22 gastroenterologists' offices over a 2-month period in 2005. 116 (44%) patients were excluded because they had not had at least one medical visit at their referred gastroenterologist during the preceding 6 months. Medical records for 8 additional patients (3%) were not accessible. 136 (53%) medical records including 148 encounters were available for analysis. Overall, elements necessary to determine the appropriateness of treatment were available in 94% (139/148) of encounters. These elements were available in more than 90% of cases for all CD categories except for mild-moderate luminal active CD where 66% were available. Among those with all necessary elements available, 18% of treatments were judged as appropriate, 29% inappropriate, 38% uncertain according to the EPACT criteria, and for the other 15%, appropriateness had not been rated by the EPACT panel.
CONCLUSIONS: The information necessary to assess the appropriateness of treatment of major types of CD was generally both present and precise in medical records. Therefore, in addition to the intended prospective use of these criteria, retrospective evaluation of the appropriateness of CD treatment using medical records is also feasible with the EPACT criteria. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17429207     DOI: 10.1159/000101566

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  3 in total

1.  Association between the appropriateness of surgery, according to appropriate use criteria, and patient-rated outcomes after surgery for lumbar degenerative spondylolisthesis.

Authors:  Anne F Mannion; Francine Mariaux; Valérie Pittet; Felix Steiger; Martin Aepli; Tamás F Fekete; Dezső Jeszenszky; Dave O'Riordan; François Porchet
Journal:  Eur Spine J       Date:  2021-02-11       Impact factor: 3.134

2.  The use of infliximab in the prevention of postsurgical recurrence in polysurgery Crohn's disease patients: a pilot open-labeled prospective study.

Authors:  Atsushi Sakuraba; Toshiro Sato; Hidehiko Matsukawa; Susumu Okamoto; Hiromasa Takaishi; Haruhiko Ogata; Yasushi Iwao; Toshifumi Hibi
Journal:  Int J Colorectal Dis       Date:  2012-01-11       Impact factor: 2.571

3.  Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.

Authors:  Atsushi Sakuraba; Kian Keyashian; Chase Correia; John Melek; Russell D Cohen; Stephen B Hanauer; David T Rubin
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.